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Detecting intracellular proteolysis <p>A new system based on non-conventional secretion of the luciferase from Gaussia princeps (GLUC) can be used to detect intracellular  proteolysis in vivo.</p>
Abstract
Protein cleavage is a central event in many regulated biological processes. We describe a system
for detecting intracellular proteolysis based on non-conventional secretion of Gaussia luciferase
(GLUC). GLUC exits the cell without benefit of a secretory leader peptide, but can be anchored
in the cell by fusion to β-actin. By including protease cleavage sites between GLUC and β-actin,
proteolytic cleavage can be detected. Using this assay, we have identified regulators of autophagy,
apoptosis and β-actin cleavage.
Background
Advances in automation and the availability of genomic
sequence information have led to the development of sophis-
ticated cell-based assays for high-throughput screening of
functional phenotypes [1]. Most cell-based assays rely on flu-
orescent or luminescent reporters such as green fluorescent
protein (GFP), secreted alkaline phosphatase (SEAP) or
Photinus luciferase. Secreted luciferases offer many advan-
t a g e s  o v e r  c e l l u l a r  r e p o r t e r  e n z y m e s  a s  t h e y  c a n  b e  n o n -
destructively harvested from cellular supernatants over time.
Several secreted luciferases have been reported, from the
marine copepods Gaussia princeps [2], and Metridia longa
[3], the ostracod Vargula hilgendorfii [4], the decapod
shrimp Oplophorus gracilirostris [5] and the ostracod crus-
tacean Cypridina noctiluca [6]. In addition, intracellular luci-
ferases, such as from the sea pansy Renilla reniformis, can be
engineered to be secreted and stable in the extra-cellular
milieu [7].
A cDNA encoding G. princeps luciferase (GLUC) activity has
recently been isolated and found to direct the synthesis of a
19.9 kDa protein that has utility as a bioluminescent reporter
[2]. GLUC can be used to monitor in vivo processes and can
be easily harvested from biological fluids such as blood or
urine [8]. Assays based on GLUC activity have been used to
study, among other topics, processing through the secretory
pathway [9], the strength of signal peptides [10], endoplasmic
reticulum (ER) stress [11], DNA hybridization [12], and pro-
tein-protein interaction using complementary fragments
derived from the enzyme [13]. By deletion of the signal pep-
tide, a GLUC mutant has been engineered for monitoring in
vivo gene expression; very low bioluminescence was detected
in cell culture superanatants upon expression of this con-
struct [2]. However, overall bioluminescence of this construct
was greatly reduced compared to wild-type GLUC [2]. It has
been noted that GLUC is secreted when fused to the ER reten-
tion signal KDEL, which has been attributed to changes in the
protein conformation or processing in the ER and Golgi [2].
We have generated a GLUC variant that is secreted in the
absence of a signal peptide. We present here a cell-based
assay for the detection of general protease activity based on
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inducible luciferase secretion. GLUC can be anchored in cells
by fusion to β-actin. Insertion of protease cleavage sites in a
linker between β-actin and GLUC allows monitoring the
cleavage of short peptides, as well as cleavage of native full-
length proteins of any sequence inserted. We present GLUC-
based reporter systems for monitoring apoptosis and
autophagy and describe applications of this reporter in
genome-wide screening approaches.
Results
In the course of attempts to develop a GLUC reporter that is
retained in cells and released after addition of a specific stim-
ulus, we deleted the signal peptide to generate dNGLUC. Sur-
prisingly, this deletion did not abolish the accumulation of
GLUC activity in the supernatant (SN) of transiently trans-
fected 293ET cells. Although the proportion of dNGLUC in
SN was reduced to 30.5% compared to 96.7% of total GLUC
activity, the overall activity was still very high (Table 1). By
contrast, when dNGLUC was fused to the carboxyl terminus
of β-actin, less than 1.5% of GLUC activity was detected in SN
(Table 1), and the relative light unit values observed were
close to background (not shown).
Most extracellular proteins are secreted from cells by trans-
port through a secretory pathway that requires translocation
of the nascent polypeptide from the ribosome to the lumen of
the ER, followed by vesicular transport through the Golgi and
subsequent compartments [14]. Initiation of secretion by this
pathway is mediated by a hydrophobic amino-terminal signal
sequence [14]. Some proteins, however, lack an amino-termi-
nal signal peptide and are secreted by a mechanism that is
insensitive to treatment with inhibitors of ER/Golgi traffick-
ing such as Brefeldin A [15,16]. To further characterize the
mechanism of secretion of dNGLUC, we treated 293ET cells
expressing dNGLUC with drugs known to interfere with
secretory pathways. Cells expressing dNGLUC were exposed
to 7 μM Monensin, 10 μg/ml Brefeldin A or 5 μg/ml MG132
and the activity accumulating over 4 h at 37°C was deter-
mined (Figure 1a). For comparison, we also measured the
activity of SEAP, which is secreted by a classical signal pep-
tide (Figure 1b). We found that treatment with Monensin and
Brefeldin A reduced secretion of both dNGLUC (by 75% and
82%, respectively; Figure 1a) and SEAP (by 88% and 90%,
respectively; Figure 1b), while MG132, an inhibitor of the pro-
teasome, reduced secretion by 32%. Since Monensin and
Brefeldin A interfere with transport pathways originating
from the Golgi apparatus, we propose that dNGLUC is
secreted by a mechanism involving the secretory pathway. To
confirm this hypothesis, we performed co-localization studies
of dNGLUC and the Golgi marker protein Golgin-67. GFP-
tagged dNGLUC was localized in the cytoplasm. In addition,
we observed co-localization of GFP-dNGLUC and DsRed-
tagged Golgin-67 at a perinuclear site (Figure 1c). Co-localiza-
tion with Golgi-resident proteins is consistent with the view
that secretion of dNGLUC requires ER/Golgi trafficking. As
far as we are aware, the dNGLUC secretory pathway is pres-
ently the first example of Brefeldin A-sensitive non-conven-
tional secretion.
The intracellular retention of Actin-dNGLUC opened the pos-
sibility of developing an assay for release of dNGLUC by pro-
tease-mediated cleavage. We inserted two tandem repeats of
the caspase 9 protease consensus site DEVDG and a Flag tag
between β-actin and dNGLUC to generate two candidate cas-
pase sensors, Actin-DEVDG2-flagdNGLUC (DEVDG2F) and
Actin-flagDEVDG2-dNGLUC (FDEVDG2) (Figure 2a). In co-
transfection experiments in which variable amounts of cas-
pase 8 or caspase 9 expression plasmid were co-delivered
with a fixed amount of dNGLUC expression plasmid,
dNGLUC activity was released into SN in a dose-dependent
manner with increasing amounts of expression plasmid (Fig-
ure 2b). Luciferase activity in the SN was 4.8-fold, 9.3-fold
and 32.8-fold higher in the presence of 10 ng, 100 ng and
1,000 ng of caspase 8, respectively, compared to control cells
transfected with vector alone. Expression of caspase 9
resulted in 2.8-fold and 12.6-fold increases of released luci-
ferase activity from FDEVDG in the presence of 100 ng and
1,000 ng of caspase 9, respectively (Figure 2b). We did not
observe release of dNGLUC from cells expressing Actin-
dNGLUC in the presence of caspase 8 or 9, confirming the
specificity of cleavage for the DEVDG motif. In order to visu-
alize the cleavage products, cell lysates from 293ET cells
expressing FDEVDG2 were resolved by SDS-PAGE and
immuno-blotted with anti-Flag antibodies. A band was
detected at a size of 62 kDa, which corresponds to the calcu-
lated molecular size (61.5 kDa) of FDEVDG2 (Figure 2c,
upper panel). In the presence of caspase 9, full-length
FDEVDG2 was not detected, but a band at 46 kDa appeared,
consistent with the removal of dNGLUC. Probing of the same
blot with an antibody raised against GLUC identified a major
band at 62 kDa that disappeared upon expression of caspase
9 (Figure 2c, lower panel).
In order to identify novel proteins that might induce caspase-
mediated cleavage, we performed a functional screen using
the Origene Trueclone™ expression vector collection. We co-
transfected 96-well plates with single cDNA expression vec-
tors and DEVDG2F and measured luciferase activity in SN
and cellular lysates in triplicate plates. To normalize for cellu-
Table 1
dNGLUC is secreted in the absence of a signal peptide
% secreted
GLUC 96.7 ± 27.6
dNGLUC 30.5 ± 7.8
Actin-dNGLUC 1.5 ± 0.4
GLUC activity was determined in SN and whole cell lysate of 293ET 
cells transfected with the indicated constructs. The percentage of 
secreted Gaussia luciferase activity was calculated from three 
independent transfections.http://genomebiology.com/2008/9/4/R64 Genome Biology 2008,     Volume 9, Issue 4, Article R64       Ketteler et al. R64.3
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dNGLUC secretion is Monensin and Brefeldin A-sensitive Figure 1
dNGLUC secretion is Monensin and Brefeldin A-sensitive. (a, b) Monensin and Brefeldin A inhibit non-conventional secretion of dNGLUC (a) and 
secreted alkaline phosphatase (SEAP) (b). Twenty-four hours after transfection of 293ET with dNGLUC, medium was replaced with medium containing 7 
μM Monensin (Mon), 10 μg/ml Brefeldin A (Bref) and 5 μg/ml MG132 or Methanol (Me). SN was collected after 4 h prior to analysis of GLUC or SEAP 
activity in the supernatant. NT, not transfected; RLU, relative light units.) (c) Co-localization of GFP-dNGLUC and Golgin-67. 293ET cells were 
transfected with GFP-dNGLUC and Golgin67-DsRed and cells were fixed with 4% paraformaldehyde prior to analysis by confocal microscopy. Overlap of 
GFP-dNGLUC and Golgin67-DsRed is marked by an arrow.
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lar expression and cell numbers, we determined the ratio of
luciferase activity in SN over cellular lysates from the same
96-well plate. Three wells on each plate were transfected with
DEVDG2F only to determine the level of background secre-
tion. In Table 2, we summarize genes that showed more than
a three-fold increase in GLUC activity released from cells
expressing DEVDG2F compared to cells transfected with
reporter only. The candidates found include known inducers
of apoptosis, such as BAK, FADD, BAD and caspase 8, in par-
tial validation of the approach to identify regulators of cas-
pase activation. In addition, we identified the novel genes for
ASPH, PIR121, PERP and TBC1D10A, which induced 14.2-,
12.1-, 10.4- and 5.5-fold increases in GLUC activity in SN from
DEVDG2F cells, respectively (Table 2). TBC1D10A is a mem-
ber of the Tre/Bub2/Cdc16 (TBC) family that exhibits GTPase
activating protein (GAP) activity and, thus, is an interesting
candidate gene in the context of apoptotic signaling. Since
DEVDG2F harbors additional aspartate residues within the
Flag peptide sequence that might serve as cleavage target
sites, we also generated a construct with three DEVDG-
repeats without a Flag tag, Actin-DEVDG3-dNGLUC
(DEVDG3). In addition, we generated a variant reporter in
which the DEVDG-motif was replaced with a DEVAG motif
that is not a substrate for caspases. TBC1D10A was co-trans-
fected with Actin-dNGLUC, DEVDG3 or DEVAG2F and the
release of GLUC into SN was measured. Caspase 9 induced a
4.1-fold and TBC1D10A a 4.3-fold increase in extra-cellular
GLUC activity compared to GFP, but did not release dNGLUC
from Actin-dNGLUC or DEVAG2F (Figure 3a). These results
are consistent with the view that the cleavage promoted by
caspase 9 and TBC1D10A is specific to the caspase cleavage
site introduced in the reporter substrate.
In the course of the screen we also identified genes that
induce release of dNGLUC from Actin-dNGLUC. Co-expres-
sion of the serine peptidase HTRA4 with ActindNGLUC or
DEVDG2F yielded a 201.5-fold increase of GLUC activity in
S N  f r o m  c e l l s  e x p r e s s i n g  A c t i n - d N G L U C  a n d  a  1 1 0 . 8 - f o l d
increase from DEVDG2F, indicating that the caspase cleavage
site is not required for liberation of luciferase activity (Figure
3b). Similarly, another family member, HTRA3, induced a
177.1-fold and 89.1-fold increase in GLUC activity in SN for
Actin-dNGLUC and DEVDG2F, respectively. Caspases 8 and
9 induced a 9.5-fold and 15.0-fold increase of GLUC activity
for DEVDG2F, but had no effect on Actin-dNGLUC. In
accordance with previous reports that have identified
HTRA2-mediated cleavage of β-actin by mass spectroscopy
[17], these data support the view that HTRA3 and 4 cleave
within the β-actin sequence. We therefore conclude that our
assay also allows the detection of full-length protein cleavage
under physiological conditions.
To further explore the suitability of GLUC fusions for detec-
tion of native protein cleavage, we inserted the open reading
frame of hMAP1LC3 (LC3), a marker of autophagy, between
β-actin and dNGLUC. Autophagy is a tightly regulated cellu-
lar response to starvation that results in degradation of sub-
cellular organelles. LC3 is cleaved during autophagy at the
carboxyl terminus by the cellular protease hATG4B; the
cleaved form is found associated with autophagosomes [18].
Amino acid starvation or treatment with rapamycin is suffi-
cient to induce autophagy and LC3 cleavage. Upon treatment
with 200 nM rapamycin, we detected a 7.2-fold increase in
GLUC activity in SN in cells expressing Actin-LC3-dNGLUC
but not Actin-dNGLUC (Figure 4a). In addition, co-expres-
sion of the cellular protease ATG4B, but not ATG4A or GFP,
resulted in a 26.6-fold increase in extra-cellular luciferase
activity (Figure 4b). Activity of ATG4B was confirmed by
immunoblotting of transfected GFP-LC3. In the presence of
ATG4B, the cleaved form of GFP-LC3 was visualized at 43
kDa and significantly increased in intensity compared to the
full-length 45 kDa form, which was not evident in cells trans-
fected with ATG4A (Figure 4c). In order to confirm cleavage
of Actin-LC3-dNGLUC by ATG4B, we resolved whole cell
lysates by SDS-PAGE and immuno-blotting using an anti-
body raised against dNGLUC as a probe. In the absence of
ATG4B, we detected the full-length construct Actin-LC3-
dNGLUC at 83 kDa and a smaller band at 23 kDa (Figure 4d).
In cells cotransfected with an ATG4B expression plasmid, the
full-length product at 83 kDa disappeared; whereas in cells
cotransfected with a GFP expression plasmid, the 83 kDa
product was readily apparent (Figure 4d). To visualize the
secreted cleavage product, we treated cells with Brefeldin A
for 6 hours prior to cell lysis. In the setting of ATG4B coex-
pression in Brefeldin A-treated cells, the band corresponding
to Actin-LC3-dNGLUC at 83 kDa is not seen and the 23 kDa
band corresponding to the dNGLUC cleavage product has
increased intensity, consistent with the view that Actin-LC3-
dNGLUC is cleaved by ATG4B.
To study the role of endogenous proteins in the autophagy
pathway, we used small hairpin RNA (shRNA)-mediated
knockdown of candidate signaling molecules. We first identi-
fied a shRNA sequence targeting human ATG4B (sh4B) that
significantly reduced the expression of a GFP-ATG4B con-
struct by 80% of detected GFP mean fluorescence intensity in
293ET cells (Figure 5a). The dNGLUC activity in the SN of
293ET cells cotransfected with Actin-LC3-dNGLUC and sh4B
was reduced by 40% compared to cells transfected with Actin-
LC3-dNGLUC alone, indicating that endogenous ATG4B con-
tributes to the observed luciferase release (Figure 5b). Next,
we tested the effect of shRNA-mediated knockdown of AKT1,
an upstream kinase that activates the key inhibitor of
autophagy, mTOR [19]. Knockdown of AKT1 resulted in an
increase of dNGLUC release from cells expressing Actin-LC3-
dNGLUC compared to vector control in transient transfection
as well as in a stable 293ET cell line expressing Actin-LC3-
dNGLUC transfected with shAKT1 (Figure 5c,d). The
magnitude of the effect of shRNA knockdown was similar to
that observed following inhibition of mTOR with rapamycin
(Figure 4a).http://genomebiology.com/2008/9/4/R64 Genome Biology 2008,     Volume 9, Issue 4, Article R64       Ketteler et al. R64.5
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Design of a GLUC-based caspase sensor Figure 2 
Design of a GLUC-based caspase sensor. (a) Schematic representation of Actin-dN, DEVDG2F, FDEVDG2, DEVDG3 and DEVAG2F. Actin, grey box; 
dNGLUC, shaded box. (b) Activation of FDEVDG2 by caspase 8 and 9. 293ET cells were co-transfected with 500 ng of Actin-dN or FDEVDG2 and the 
indicated amounts of caspase 8 (left panel) or caspase 9 (right panel) in a 12-well plate. SN was tested for GLUC activity after 30 h. Error bars were 
calculated from three independent transfections. RLU, relative light units. (c) Immune-blotting of cleaved FDEVDG2. Transiently transfected 293ET cells 
expressing FDEVDG2 together with GFP or caspase 9 were grown for 30 h prior to cell lysis. Lysates were resolved by 10% PAGE and immune-blots 
were analyzed with anti-Flag M2 (upper panel) or anti-GLUC (lower panel) antibody. Full-length FDEVDG2 migrates at 62 kDa (marked by an asterisk) and 
caspase 9-cleaved Actin-FDEVDG2 migrates around 46 kDa (marked by an arrow).
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Discussion
Non-conventional secretion of Gaussia luciferase
Protein secretion in most cells is mediated by signal
sequences that target the nascent polypeptide chain of the
elongating translation product to a secretory pore in the ER
[14]. Within the ER and the subsequent compartments of the
Golgi apparatus, folding and post-translational modifications
take place, and the mature, modified polypeptide is released
into the extracellular space. A number of secreted proteins
that do not utilize the ER membrane translocation machin-
ery, such as fibroblast growth factor, coagulation factor XIII
and interleukin-1β are secreted by a non-conventional secre-
tory pathway [16]. Different mechanisms for non-conven-
tional secretion have been proposed [16], including lysosomal
secretion for interleukin-1β [20], a plasma resident trans-
porter for fibroblast growth factor 2 [21] and cell injury for
coagulation factor XIII [22]. Two prevalent features of non-
conventional secretion are the absence of a signal peptide and
insensitivity to Brefeldin A [15]. The precise mechanism of
secretion is still poorly understood and the underlying molec-
ular signals remain to be elucidated.
The luciferase release assay reported here relies on a non-
conventional secretion of dNGLUC that is inhibited by Mon-
ensin and Brefeldin A. Monensin inhibits acidification of ter-
minal compartments thought to lie immediately prior to
extracellular release, whereas Brefeldin A inhibits ER-to-
Golgi transport. The amino-terminal amino acid sequence of
the deleted luciferase studied here does not fulfill the
accepted criteria for a signal peptide [23]. Because secretion
is sensitive to treatment with Brefeldin A, we conclude that a
previously unarticulated mechanism is responsible for the
translocation of the polypeptide into the ER and/or Golgi.
The molecular basis of this translocation, and subsequent
passage through the terminal secretory apparatus, is pres-
ently under investigation. A Golgi-resident protein, GRASP,
has been identified that is required for a non-conventional
secretory pathway in Dictyostelium discoideum [24] and
Drosophila melanogaster [25], and that is a candidate for
mediating Brefeldin A-sensitive secretion of dNGLUC.
Identification of GLUC mutants that are retained inside cells
may help to identify the mechanism of non-conventional
secretion.
A novel protease assay
The present assay system has several advantages over exist-
ing systems for measuring protease activity. Currently, pro-
tease cleavage sites can be inferred from comparison of
primary sequences. The physiological relevance of predicted
cleavage sites in a particular protein then can be assessed by
further experimentation. Target motifs can be identified by
analysis of protease action on peptide libraries, such as phage
Table 2
Genes that induce release of dNGLUC activity in SN
Gene Fold ratio SN/cells
ASPH 14.2 ± 5.8
BAK1 12.5 ± 2.3
PIR121 12.1 ± 2.7
PERP 10.4 ± 2.5
TBC1D10A 5.5 ± 2.7
FADD 4.9 ± 1.8
BAD 4.8 ± 2.7
CASP8 3.2 ± 1.1
Cells were transfected in 96-well plates with DEVDG2F and cDNA 
expression vectors from the Origene Trueclone™ collection in 
triplicates. Activity of GLUC was measured in SN and cell lysates after 
26 h and ratios of SN/cellular activity were calculated for each plate. 
Three wells on each plate were transfected with reporter only to 
determine the background activity. We show the fold ratio of SN/
cellular activity over background averaged from three plates.
HTRA3 and 4 release GLUC activity from Actin-dNGLUC Figure 3
HTRA3 and 4 release GLUC activity from Actin-dNGLUC. (a) Actin-
dNGLUC, DEVDG3 or DEVAG2F were co-transfected with GFP, caspase 
9 or TBC1D10A and GLUC activity in SN was assayed after 30 h. 
TBC1D10A specifically releases dNGLUC from DEVDG3, but not 
DEVAG2F (RLU, relative light units). (b) HTRA3 and 4 release GLUC 
activity from Actin-dNGLUC. Caspase 8, caspase 9, HTRA3 and HTRA4 
were co-transfected with Actin-dNGLUC and DEVDG2F and SN were 
analyzed for GLUC activity in SN after 30 h. HTRA3 and 4 release GLUC 
activity from Actin-dN and DEVDG2F, while caspases 8 and 9 released 
GLUC activity from DEVDG2F but not Actin.
0
40000
80000
120000
160000
200000
R
.
L
.
U
m
o
c
k
C
a
s
p
9
H
t
r
A
4
C
a
s
p
8
H
t
r
A
3
G
F
P
Actin-dN DEVDG2F
m
o
c
k
C
a
s
p
9
H
t
r
A
4
C
a
s
p
8
H
t
r
A
3
G
F
P
0
2000
4000
6000
8000
10000
GFP CASP9
R
.
L
.
U
A
c
t
i
n
-
d
N
D
E
V
D
G
3
D
E
V
A
G
F
TBC1D10A
A
c
t
i
n
-
d
N
D
E
V
D
G
3
D
E
V
A
G
F
A
c
t
i
n
-
d
N
D
E
V
D
G
3
D
E
V
A
G
F
(a)
(b)http://genomebiology.com/2008/9/4/R64 Genome Biology 2008,     Volume 9, Issue 4, Article R64       Ketteler et al. R64.7
Genome Biology 2008, 9:R64
display libraries, positional-scanning libraries and mixture-
based libraries [26]. The identification of protein cleavage in
the context of live cells can be achieved by mass spectroscopic
analysis of cleavage products [27], but requires a complex
experimental setup and is not amenable to high-throughput
approaches. Other cell-based protease assays rely on genera-
tion of a fluorogenic substrate upon cleavage, but these assays
are not genetically encoded, thus limiting their applicability
in vivo. Some in vivo protease assays have been developed
that exploit the properties of fluorescence resonance energy
transfer (FRET) [28]; in these, the protease-mediated
separation of a donor and acceptor fluorophore results in
changes of the ratio of fluorescence intensities at different
wavelengths [29]. A major advantage of FRET-based meth-
ods is their ability to provide information about the sub-cellu-
A GLUC-based sensor to monitor autophagy Figure 4
A GLUC-based sensor to monitor autophagy. (a) Rapamycin (Rap) 
induces release of GLUC activity from Actin-LC3-dN. Actin-LC3-dN was 
transfected in 293ET cells and medium was replaced after 24 h with 
serum-free medium containing 200 nM rapamycin for 6 h before analysis of 
GLUC activity in SN. (b) ATG4B but not ATG4A induces cleavage of 
Actin-LC3-dN. SN of 293ET cells transiently co-transfected with Actin-dN 
or Actin-LC3-dN and GFP, ATG4A or ATG4B were collected after 24 h 
and analyzed for GLUC activity. Error bars were calculated from three 
independent transfections. RLU, relative light units. (c) ATG4B cleaves 
GFP-LC3. 293ET cells transfected with GFP-LC3 and ATG4A or ATG4B 
were lysed in 1% NP40, resolved by 10% SDS-PAGE and blotted with anti-
GFP. Full-length GFP-LC3 (LC I) runs at 45 kDa and the cleaved product 
runs at 43 kDa (LC II). (d) ATG4B cleaves Actin-LC3-dN to generate a 
small LC3-dNGLUC fragment. 293ET cells transfected with Actin-LC3-dN 
and GFP or ATG4B were treated for 6 h with 10 μg/ml Brefeldin A (right 
panel) to block secretion of cleaved dNGLUC or left untreated (left panel) 
before lysis in 1% NP40. Whole cell lysates were resolved by 10% SDS 
PAGE and blotted with an antibody raised against dNGLUC. The protein 
band corresponding to full-length Actin-LC3-dN is marked with an 
asterisk, the cleavage product is marked with an arrowhead.
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shRNA targeting AKT1 enhances autophagy Figure 5
shRNA targeting AKT1 enhances autophagy. (a) shRNA targeting human 
ATG4B (sh4B) reduces expression of a GFP-ATG4B fusion protein. 293ET 
cells expressing GFP-ATG4B (GFP-4B) with vector control or shRNA 
targeting ATG4B were analyzed for mean fluorescence intensity (MFI) by 
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lar localization of protease activity. However, FRET-based
assays are frequently not highly sensitive, require a carefully
characterized cohort of control samples in a single
experiment and typically demand advanced instrumentation.
To date there has been little use of FRET in genomic screen-
ing applications. In contrast, the assay system described here
non-invasively measures protein cleavage over time in the
context of the complex physiology of intact living cells, is
compatible with high-throughput screening methodologies,
and can be designed to monitor protease function with high
specificity. The luciferase release system can detect cleavage
of short peptides as well as cleavage of full-length proteins.
Evaluation of actin-specific or non-specific screening hits can
be identified and eliminated by secondary screening with a
luciferase fusion bearing a mutated version of the protease
cleavage motif to be investigated. It has previously been
established that GLUC secretion is proportional to cell
number [2]. Differences in cell number as well as variation in
transcription and translation rate can be assessed by deter-
mining ratios of extracellular luciferase to cellular activity.
We recommend that the optimal harvest and collection times
be assessed in pilot studies. For instance, extensive cell death
results in reduced reporter production, and in the case of the
apoptosis sensor used here, best results were seen when the
cultures were assayed 24-32 hours after initiation of apopto-
sis. The assay is highly reproducible following transient trans-
fection, and can also be used in cell lines stably transfected
with the reporter if desired. Both transfected and endogenous
protease activities are easily detected with this system. The
transfer of a reporter enzyme across cell membranes
constitutes an unexpected assay principle that adds a flexible,
broadly applicable approach to current cell-based multi-color
and multienzyme assays.
Applications of the protease sensor to study β-actin 
cleavage, apoptosis and autophagy
Cleavage of Actin-dNGLUC by HtrA3 and 4 suggests that
members of the HtrA family of heat shock proteases, which
are known to have significant functions in protein folding and
apoptosis, may have the general property of cleaving actin in
a manner that eliminates its ability to form insoluble fibers.
Recently, a proteomic approach based on mass spectroscopic
identification of cleavage products was undertaken to identify
HTRA2 substrates [17]. Major cleavage products included β-
actin and tubulin alpha/beta and it was suggested that
HTRA2 regulates apoptosis at the level of the cytoskeleton
[17]. Although β-actin has been reported as a substrate for a
number of caspases, including caspase 3 [30], we have not
observed release of dNGLUC from Actin-dNGLUC in
response to caspase 3, 8 or 9, suggesting either that cleavage
did not occur, or that it did not impair the ability of β-actin to
anchor dNGLUC in the cell. In contrast to observations on
cell-free extracts, cleavage of β-actin by caspases has not been
detected in intact cells [31].
In a functional screen using the caspase sensor, we have iden-
tified the TBC family member TBC1D10A as an inducer of
DEVDG-mediated cleavage. The TBC family of proteins
exhibit GAP activity towards small GTPases of the Rab family
[32]. TBC1D10A has recently been identified as a GAP for
Rab27A, suggesting a role in melanocyte transport and secre-
tion [33]. In addition, TBC1D10A binds to a complex of
EBP50 with Ezrin and ARF6-GTP to regulate microvillus
structure [34]. Based on these data, TBC1D10A has been
proposed as a regulator of protein trafficking in cells.
Recently, a genome-wide screen for cell death effectors iden-
tified another family member, TBC1D10C, as an inducer of
apoptosis [35]. In agreement with this observation, our find-
ings confirm a role for TBC1D10A as an effector of protein
cleavage.
Autophagy is an essential cellular process for the degradation
of proteins and organelles that has been associated with neu-
rogenerative diseases, cancer and infection [36]. Although
autophagy is currently widely investigated, the systematic
identification of molecular events in autophagy has been
hampered by the lack of suitable assays. Current assays to
study autophagy measure the accumulation of autophagic
vacuoles by staining with fluorescent dyes such as monodan-
sylcadaverine [37], or the sequestration of radioactive sugars
or enzymes such as lactate dehydrogenase [38]. However,
these assays are difficult to quantify due to the presence of
background levels of autophagic vacuoles or non-specific
staining. Recently, immuno-blotting of hMAP1LC3 cleavage
products, and GFPhMAP1LC3 translocation to
autophagosomes [18] have been proposed as specific assays
for autophagy. However, since the cleavage product of
hMAP1LC3 is itself degraded by autophagy, interpretation of
these assays requires additional controls [39]. The assay pre-
sented here is a simple, easily implemented, quantitative
assay that measures induction of autophagy without destruc-
tion of the cell being studied. As such, we anticipate it will be
useful to many investigators in their studies of this enigmatic
process.
Conclusion
It has been estimated that the human genome contains more
than 500 proteases [40], most of which are poorly character-
ized. The luciferase secretion assay described here can be
used to identify protease regulatory pathways as well as pro-
tease targets. The actions of nongenomic proteases, such as
the HIV or HCV proteases or Anthrax lethal factor can be eas-
ily assessed by inserting the appropriate peptide target
sequence in an actin-peptide-dNGLUC reporter construct.
The finding that Gaussia luciferase is capable of exiting the
cell by a non-conventional secretion pathway is unusual in
itself, and provides a tool to explore aspects of non-conven-
tional secretion. Regulated non-conventional secretion of an
enzymatic reporter has not been previously demonstrated tohttp://genomebiology.com/2008/9/4/R64 Genome Biology 2008,     Volume 9, Issue 4, Article R64       Ketteler et al. R64.9
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our knowledge, and affords several advantages over existing
methods for analysis of intracellular cleavage events.
Of particular interest is the process of autophagy. Autophagy
is a highly regulated process that appears to provide addi-
tional energy to cells under conditions of starvation.
Autophagy has been suggested to play roles in the prevention
and progression of cancers [41]. The precise role that
autophagy plays in these settings is not well understood, and
high interest is currently directed toward understanding the
contribution of autophagy to tumor growth. Large-scale
screening approaches to identify regulators of autophagy to
date have not been reported, possibly due to the absence of
suitable screening assays. Analysis of autophagy is presently
based on qualitative ultramorphological analyses, immunob-
lotting, or translocation of GFPLC3. Such assays can be non-
quantitative, laborious and subject to multiple confounding
factors [39]. The analysis system described here facilitates
insight into the regulation of autophagy and enables large
scale shRNA knockdown and expression screening
approaches.
Materials and methods
Plasmids
A GLUC sequence optimized for expression in both
Escherichia coli and Homo sapiens was synthesized by tan-
dem DNA oligonucleotide annealing and sub-cloned into
pEAK12. During this process, the carboxy-terminal amino
acid sequence LYK was added. Human β-actin was amplified
from Origene Trueclone™ (AB1024H03) and inserted into
the  HindIII and NotI sites in pEAK12 using primers 5'-
GACAAGCTTATGGATGATGATATCGCC-3' and 5'-GACGCG-
GCCGCTTAGAATTCGAAGCATTTGCGGTG-3'. dNGLUC
was amplified by PCR using primers 5'-GACGAATTCAT-
GCTAGCCAAGCCCACCG-3' and 5'-GGCTACTCTAGGGCAC-
CTGTCCCGCC-3' and sub-cloned into pEAK12-βActin by
digestion with EcoRI and NotI. A DEVDG(2)-Flag sequence
was inserted at EcoRI as an adapter with the sequences 5'-
AATTGGACGAGGTGGACGGCGACGAGGTGGACGGCGAC-
TACAAGGACGA CGACGACAAGGAATTCGC-3' and 5'-
GGCCGCGAATTCCTTGTCGTCGTCGTCCTTGTAGTCGC-
CGTCCACCTCGTC GCCGTCCACCTCGTCC-3' to generate
pEAK12-Actin-DEVDG2flag-dNGLUC (DEVDG2F). Simi-
larly, Actin-flagDEVDG2-dNGLUC (FDEVDG2) was con-
structed by inserting the Flag sequence before the DEVDG2
motif. A mutant Actin-DEVAG2flag-dNGLUC (DEVAG2F)
construct was inserted with the same strategy. Actin-
DEVDG3-dNGLUC (DEVDG3) was generated by introduc-
tion of three adjacent DEVDG sites. The Actin-LC3-dNGLUC
construct was generated by PCR of hMAP1LC3 (Origene
Trueclone AB2841G10) using primers 5'-GACGAATTCAT-
GCCGTCGGAGAAGAC-3' and 5'-GACGCGGCCGCTTAG-
GATCCCACTGACAATTTCATCCC-3' and sub-cloned into the
EcoRI and NotI site of pMOWSdSV. dNGLUC was amplified
by PCR and inserted into the BamHI and NotI site of
pMOWSdSV-LC3. The LC3-dNGLUC fusion was transferred
by EcoRI and NotI digestion of pEAK12-β-actin to generate
pEAK12-Actin-LC3-dNGLUC. GFP-dNGLUC was con-
structed by subcloning of dNGLUC into pEAK12-GFP using
the EcoRI and NotI restriction sites. To generate Golgin67-
DsRed, Golgin67 (Origene Trueclone AB1045_E08) was
amplified by PCR and subcloned into pEAK12-GFP using
HindIII and NotI restriction sites. DsRedExpress1 (Clontech,
Mountain View, CA, USA) was amplified by PCR and sub-
cloned in frame using EcoRI and NotI restriction sites.
Expression vectors for caspase 8 and caspase 9 have been previ-
ously described [42]. shRNA vectors for knockdown of human
ATG4B (#TRCN0000073801), AKT1 (#TRCN0000010174)
and vector control pLKO1 were obtained from Sigma (St.
Louis, MO, USA).
Transfection
293ET cells were cultured in DMEM (supplemented with 10%
calf serum plus iron, 0.25 μg/ml gentamycin and 50 μM β-
mercaptoethanol) and transfected using calcium phosphate
precipitation as described elsewhere [43]. The Origene True-
clone™ cDNA library consisting of approximately 12.000
human expression cDNAs arrayed in 96-well plates were
transfected by TransFectin (BioRad, Hercules, CA, USA)
along with a GFP expression construct in 293ET cells and
screened for morphological changes by fluorescence micros-
copy (RK and BS, unpublished). Clones displaying signs of
cell death were selected for transfection with Actin-
DEVDG2F-dNGLUC. Supernatants were harvested after 24-
32 h for luciferase analysis. Inhibitors of non-conventional
secretion (7 μM Monensin, 10 μg/ml Brefeldin A, 5 μg/ml
MG132; all from Sigma) were added 24 h after transfection
and medium was collected over a 4 h time period.
Generation of stable 293ET cell line
Actin-dN and Actin-LC3-dN were subcloned into pMOWS
[43] and co-transfected in 293ET cells with expression plas-
mids for VSV-G and retroviral gag-pol. The medium was
changed after 24 h and virus supernatant was harvested and
filtered through 0.45 μm filters 48 h after transfection.
Untransfected 293ET cells were incubated with retroviral
supernatant supplemented with 8 μg/ml polybrene; 48 h
later, transduced 293ET cells were selected with puromycin
at a concentration of 0.3 μg/ml.
Western blotting
A polyclonal antibody was raised in rabbit against dNGLUC
(Proteintech Group Inc, Chicago, IL, USA). For western blot-
ting, cells were lysed in 1% NP40 lysis buffer (20 mM Tris
pH7.4, 150 mM NaCl, 1 mM EDTA, 1 mM ZnCl2, 1 mM MgCl2,
10% Glycerol) and resolved by SDS-PAGE. Proteins were
blotted onto nitrocellulose (BioRad) and immune-stained
with antibodies against dNGLUC, GFP (Covance, Princeton,
NJ, USA), and Flag M2 (Sigma).Genome Biology 2008, 9:R64
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Confocal microscopy
293ET cells were grown on coverslips and transfected by cal-
cium phosphate precipitations as described. After 24 h, cells
were fixed in 4% paraformaldehyde and mounted in aqueous
mounting agent (Polysciences, Warrington, PA, USA).
Images were obtained using confocal microscopy (BioRad
Radiance 2000) and are a flat projection of z stacks taken
throughout the plane of the transfected cell analyzed by LSM
Image software (Carl Zeiss).
Luciferase and alkaline phosphatase assay
GLUC activity was determined using the Renilla Luciferase
kit (Promega, Madison, WI, USA). To avoid harvesting luci-
ferase activity from detached cells, supernatants were spun at
14,000 rpm for 5 minutes. Unless otherwise indicated, 10 μl
of supernatant from a 12-well plate (total volume 1 ml) was
diluted 1:10 in 100 μl 1 × Renilla lysis buffer and 10 μl of this
mixture was added to 100 μl of Renilla substrate prior to anal-
ysis in a TopCount luminescence plate reader (Perkin Elmer,
Waltham, MA, USA). For 96-well plates, 20 μl of SN was
mixed with 20 μl of 2 × Renilla lysis buffer and 50 μl of Renilla
substrate was added prior to analysis in the TopCount lumi-
nescence plate reader. Cells were lysed in 50 μl of 1 × Renilla
lysis buffer and 25 μl of cell lysate was added to 50 μl of
Renilla substrate. Secreted alkaline phosphatase was deter-
mined using the Phospha-Light™ secreted alkaline phos-
phatase reporter assay system (Applied Biosystems, Foster
City, CA, USA) according to the manufacturer's instructions.
Briefly, 50 μl of SN was mixed with 150 μl 1 × dilution buffer
and incubated at 70°C for 20 minutes. Diluted SN (50 μl) was
mixed with 50 μl of assay buffer and 50 μl of substrate
solution before assaying in the TopCount luminescence plate
reader.
Abbreviations
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